New Orleans, LA - In a somewhat idiosyncratic presentation at the American Heart Association Scientific Sessions 2004, Dr Victor Serebruany (HeartDrug Research, Towson, MD) claimed that reports of ...
December 7, 2009 (Towson, Maryland) — In a new paper that turns the notion of clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-Aventis) nonresponsiveness on its head, researchers propose that a high ...
DALLAS, June 8 – A substantial proportion of heart attack patients may be resistant to the blood thinner clopidogrel – and face an increased risk of recurrent blockages, researchers report in today's ...
A commonly prescribed drug could be more effective than aspirin for long-term heart disease prevention. Analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests the blood thinner ...
Dual antiplatelet therapy with a thienopyridine in combination with aspirin for 1 to 6 months after stenting has been recommended by the manufacturers to reduce ischemic cardiovascular events and ...
ANAHEIM, CA—Making a switch from treatment with one P2Y12 inhibitor to another for any reason after an ACS is uncommon, but it’s more likely for patients initially treated with ticagrelor rather than ...
Clopidogrel is a generic prescription medication. It is FDA-approved to help prevent cardiovascular events such as heart attack and stroke in certain adults. Specifically, clopidogrel is approved to ...
Described as a 'transformation' in stroke care across NHS Scotland, the test aims to identify the most effective treatment for each patient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback